Trial Outcomes & Findings for Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD) (NCT NCT01259596)
NCT ID: NCT01259596
Last Updated: 2018-08-29
Results Overview
self-reported severity and frequency of worry the scores range from 8 to 40, with higher scores representing higher severity of worry. Higher scores represent worse outcome.
COMPLETED
NA
141 participants
baseline to week 13
2018-08-29
Participant Flow
Participant milestones
| Measure |
Cognitive-behavioral Therapy
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Overall Study
STARTED
|
70
|
71
|
|
Overall Study
COMPLETED
|
66
|
65
|
|
Overall Study
NOT COMPLETED
|
4
|
6
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)
Baseline characteristics by cohort
| Measure |
Cognitive-behavioral Therapy
n=70 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=71 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Total
n=141 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
41 Participants
n=5 Participants
|
34 Participants
n=7 Participants
|
75 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
29 Participants
n=5 Participants
|
37 Participants
n=7 Participants
|
66 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
58 Participants
n=5 Participants
|
57 Participants
n=7 Participants
|
115 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
70 Participants
n=5 Participants
|
71 Participants
n=7 Participants
|
141 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
4 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
64 Participants
n=5 Participants
|
64 Participants
n=7 Participants
|
128 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
70 participants
n=5 Participants
|
71 participants
n=7 Participants
|
141 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: baseline to week 13self-reported severity and frequency of worry the scores range from 8 to 40, with higher scores representing higher severity of worry. Higher scores represent worse outcome.
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Changes From Baseline in Penn State Worry Questionnaire (PSWQ-A) at Week 13
|
-9.44 units on a scale
Interval -11.02 to -7.86
|
-5.37 units on a scale
Interval -6.89 to -3.85
|
PRIMARY outcome
Timeframe: baseline to week 13interviewer-rated severity of anxiety symptoms; the scores range from 0 to 56, with higher scores representing higher severity of anxiety. Higher scores represent worse outcome.
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=64 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Changes From Baseline in Hamilton Anxiety Rating Scale (HAM-A) at Week 13
|
-7.04 units on a scale
Interval -8.88 to -5.21
|
-5.53 units on a scale
Interval -7.28 to -3.77
|
SECONDARY outcome
Timeframe: baseline to week 13self report measure of depressive symptoms; scores range from 0 to 63, with a higher score representing higher levels of depressive symptoms Higher scores represent worse outcome.
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=64 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Changes From Baseline in Beck Depression Inventory (BDI) at 13 Weeks
|
-10.77 units on a scale
Interval -12.73 to -8.81
|
-7.54 units on a scale
Interval -9.44 to -5.64
|
SECONDARY outcome
Timeframe: week 13self report measure of perceived difficulties with mobility and performing basic and advanced activities of daily living; the scale consists of 19 items; scores range from 19 to 114, with higher scores indicating more disability. Higher scores represent worse outcome.
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Pepper Center Tool for Disability (PCT-D)
|
1.71 units on a scale
Interval 1.55 to 1.87
|
1.86 units on a scale
Interval 1.7 to 2.01
|
SECONDARY outcome
Timeframe: week 13physical and emotional health related quality of life; The SF-36 is a self-report measure of health-related quality of life (HRQL) consisting of 36 items that form 8 subscales: physical functioning, role limitations due to physical health problems, role limitations due to emotional health problems, social functioning, freedom from pain, energy, emotional well-being, and general health perceptions. These 8 subscales are also combined into two domains: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). All of these scales range from 0 (maximum impairment) to 100 (no impairment). A lower score represents worse outcome.
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Short Form (36) Health Survey (SF-36) to Week 13
|
60.5 units on a scale
Interval 55.9 to 65.1
|
53.5 units on a scale
Interval 49.1 to 57.9
|
SECONDARY outcome
Timeframe: week 13self-report symptoms of insomnia; scores range from 0 to 28 with higher scores indicating greater symptoms of sleep disturbance; higher score represents worse outcomes
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Insomnia Severity Index (ISI)
|
8.70 units on a scale
Interval 7.1 to 10.3
|
11.9 units on a scale
Interval 10.4 to 13.4
|
SECONDARY outcome
Timeframe: baseline to week 13Diagnostic and Statistical Manual of Mental Disorders, IV edition (DSM-IV0) symptoms of Generalized Anxiety Disorder; scores range from 0 to 24 with higher scores indicating greater symptoms of GAD; higher score represents worse outcome
Outcome measures
| Measure |
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Changes From Baseline in Generalized Anxiety Disorder-7 (GAD-7) to Week 13
|
-5.63 units on a scale
Interval -6.82 to -4.44
|
-3.27 units on a scale
Interval -4.4 to -2.14
|
Adverse Events
Cognitive-behavioral Therapy
Nondirective Supportive Therapy
Serious adverse events
| Measure |
Cognitive-behavioral Therapy
n=70 participants at risk
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=71 participants at risk
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Psychiatric disorders
serious adverse event
|
0.00%
0/70
|
0.00%
0/71
|
Other adverse events
| Measure |
Cognitive-behavioral Therapy
n=70 participants at risk
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
Nondirective Supportive Therapy
n=71 participants at risk
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings
psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
|
|---|---|---|
|
Psychiatric disorders
adverse event
|
5.7%
4/70 • Number of events 4
|
5.6%
4/71 • Number of events 4
|
Additional Information
Gretchen A. Brenes, Ph.D.
Wake Forest School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place